151 related articles for article (PubMed ID: 31566139)
1. The Correlation between EGFR and Androgen Receptor Pathways: A Novel Potential Prognostic Marker in Gastric Cancer.
Fard SS; Saliminejad K; Sotoudeh M; Soleimanifard N; Kouchaki S; Yazdanbod M; Mahmoodzadeh H; Ghavamzadeh A; Malekzadeh R; Chahardouli B; Alimoghaddam K; Ghaffari SH
Anticancer Agents Med Chem; 2019; 19(17):2097-2107. PubMed ID: 31566139
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Association between Androgen Receptor and AURKA and Its Prognostic Value in Gastric Cancer.
Soleymani Fard S; Sotoudeh M; Yazdanbod M; Ghavamzadeh A; Malekzadeh R; Yaghmaie M; Mousavi SA; Ghaffari SH; Alimoghaddam K
Int J Hematol Oncol Stem Cell Res; 2019 Oct; 13(4):174-182. PubMed ID: 31871591
[No Abstract] [Full Text] [Related]
3. Investigation of the Correlation between Androgen Receptor and ZEB1 and its Value in Progression of Gastric Cancer.
Soleymani Fard S; Sotoudeh M; Saliminejad K; Yazdanbod M; Mahmoodzadeh H; Kouchaki S; Yaghmaie M; Mousavi SA; Malekzadeh R; Alimoghaddam K; Ghaffari SH
Avicenna J Med Biotechnol; 2020; 12(1):52-60. PubMed ID: 32153739
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor (AR) expression is an independent unfavorable prognostic factor in gastric cancer.
Kominea A; Konstantinopoulos PA; Kapranos N; Vandoros G; Gkermpesi M; Andricopoulos P; Artelaris S; Savva S; Varakis I; Sotiropoulou-Bonikou G; Papavassiliou AG
J Cancer Res Clin Oncol; 2004 May; 130(5):253-8. PubMed ID: 14963700
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and Therapeutic Significance of Androgen Receptor in Patients with Gastric Cancer.
Soleymani Fard S; Yazdanbod M; Sotoudeh M; Bashash D; Mahmoodzadeh H; Saliminejad K; Mousavi SA; Ghaffari SH; Alimoghaddam K
Onco Targets Ther; 2020; 13():9821-9837. PubMed ID: 33061460
[TBL] [Abstract][Full Text] [Related]
6. Androgen Receptor Activation in Glioblastoma Can Be Achieved by Ligand-Independent Signaling through EGFR-A Potential Therapeutic Target.
Zalcman N; Gutreiman M; Shahar T; Weller M; Lavon I
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681618
[TBL] [Abstract][Full Text] [Related]
7. The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer.
Mandel A; Larsson P; Sarwar M; Semenas J; Syed Khaja AS; Persson JL
Mol Med; 2018 Jun; 24(1):34. PubMed ID: 30134822
[TBL] [Abstract][Full Text] [Related]
8. Expression of estrogen receptors and androgen receptor and their clinical significance in gastric cancer.
Tang W; Liu R; Yan Y; Pan X; Wang M; Han X; Ren H; Zhang Z
Oncotarget; 2017 Jun; 8(25):40765-40777. PubMed ID: 28388558
[TBL] [Abstract][Full Text] [Related]
9. The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer.
Atmaca A; Werner D; Pauligk C; Steinmetz K; Wirtz R; Altmannsberger HM; Jäger E; Al-Batran SE
BMC Cancer; 2012 Nov; 12():524. PubMed ID: 23153332
[TBL] [Abstract][Full Text] [Related]
10. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
[TBL] [Abstract][Full Text] [Related]
11. Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells.
Zheng Y; Izumi K; Yao JL; Miyamoto H
Endocr Relat Cancer; 2011 Aug; 18(4):451-64. PubMed ID: 21613411
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor variant 12 promotes migration and invasion by regulating MYLK in gastric cancer.
Xia N; Cui J; Zhu M; Xing R; Lu Y
J Pathol; 2019 Jul; 248(3):304-315. PubMed ID: 30737779
[TBL] [Abstract][Full Text] [Related]
13. STAT3 is associated with lymph node metastasis in gastric cancer.
Deng J; Liang H; Zhang R; Sun D; Pan Y; Liu Y; Zhang L; Hao X
Tumour Biol; 2013 Oct; 34(5):2791-800. PubMed ID: 23824569
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor promotes cell stemness via interacting with co-factor YAP1 in gastric cancer.
Hou J; Pan T; Li F; Sang Q; Wu X; Li J; Yu B; Zang M; Zhu ZG; Su L; Liu B
Biochem Pharmacol; 2023 Nov; 217():115849. PubMed ID: 37806457
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Transcription Factor 7 (TCF7) as a Prognostic Factor in Gastric Cancer.
Xu X; Liu Z; Tian F; Xu J; Chen Y
Med Sci Monit; 2019 May; 25():3957-3963. PubMed ID: 31133633
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of β2-adrenergic receptor expression in patients with surgically resected gastric adenocarcinoma.
Takahashi K; Kaira K; Shimizu A; Sato T; Takahashi N; Ogawa H; Yoshinari D; Yokobori T; Asao T; Takeyoshi I; Oyama T
Tumour Biol; 2016 Oct; 37(10):13885-13892. PubMed ID: 27485115
[TBL] [Abstract][Full Text] [Related]
17. The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells.
Bonaccorsi L; Muratori M; Carloni V; Marchiani S; Formigli L; Forti G; Baldi E
Steroids; 2004 Aug; 69(8-9):549-52. PubMed ID: 15288768
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features.
Astvatsaturyan K; Yue Y; Walts AE; Bose S
PLoS One; 2018; 13(6):e0197827. PubMed ID: 29883487
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of aberrant Arpin expression in gastric cancer.
Li T; Zheng HM; Deng NM; Jiang YJ; Wang J; Zhang DL
World J Gastroenterol; 2017 Feb; 23(8):1450-1457. PubMed ID: 28293092
[TBL] [Abstract][Full Text] [Related]
20. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
